BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10632595)

  • 1. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.
    Gong YH; Parsadanian AS; Andreeva A; Snider WD; Elliott JL
    J Neurosci; 2000 Jan; 20(2):660-5. PubMed ID: 10632595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis.
    O'Reilly SA; Roedica J; Nagy D; Hallewell RA; Alderson K; Marklund SL; Kuby J; Kushner PD
    Exp Neurol; 1995 Feb; 131(2):203-10. PubMed ID: 7895821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Oostveen JA; Gurney ME
    Glia; 1998 Jul; 23(3):249-56. PubMed ID: 9633809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Almer G; Vukosavic S; Romero N; Przedborski S
    J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
    Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria.
    Bilsland LG; Nirmalananthan N; Yip J; Greensmith L; Duchen MR
    J Neurochem; 2008 Dec; 107(5):1271-83. PubMed ID: 18808448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS.
    Higgins CM; Jung C; Ding H; Xu Z
    J Neurosci; 2002 Mar; 22(6):RC215. PubMed ID: 11886899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
    Wang L; Gutmann DH; Roos RP
    Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.
    Lino MM; Schneider C; Caroni P
    J Neurosci; 2002 Jun; 22(12):4825-32. PubMed ID: 12077179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis.
    Ferraiuolo L; Higginbottom A; Heath PR; Barber S; Greenald D; Kirby J; Shaw PJ
    Brain; 2011 Sep; 134(Pt 9):2627-41. PubMed ID: 21908873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
    Gong YH; Elliott JL
    Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.
    Audet JN; Gowing G; Julien JP
    Neurobiol Dis; 2010 Oct; 40(1):245-50. PubMed ID: 20573565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Bush AI; Morrison BM; Morrison JH; Cherny RA; Volitakis I; Beal MF; Gordon JW
    J Neurosci; 2004 Sep; 24(36):7945-50. PubMed ID: 15356208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice.
    Tobisawa S; Hozumi Y; Arawaka S; Koyama S; Wada M; Nagai M; Aoki M; Itoyama Y; Goto K; Kato T
    Biochem Biophys Res Commun; 2003 Apr; 303(2):496-503. PubMed ID: 12659845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.
    Tu PH; Raju P; Robinson KA; Gurney ME; Trojanowski JQ; Lee VM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3155-60. PubMed ID: 8610185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.